Abahssain, H.; Souadka, A.; Alem, R.; Santoni, M.; Battelli, N.; Amela, E.; Lemaire, A.; Rodriguez, J.; Errihani, H.
Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting. Curr. Oncol. 2024, 31, 3771-3782.
https://doi.org/10.3390/curroncol31070278
AMA Style
Abahssain H, Souadka A, Alem R, Santoni M, Battelli N, Amela E, Lemaire A, Rodriguez J, Errihani H.
Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting. Current Oncology. 2024; 31(7):3771-3782.
https://doi.org/10.3390/curroncol31070278
Chicago/Turabian Style
Abahssain, Halima, Amine Souadka, Rania Alem, Matteo Santoni, Nicola Battelli, Eric Amela, Antoine Lemaire, Joseph Rodriguez, and Hassan Errihani.
2024. "Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting" Current Oncology 31, no. 7: 3771-3782.
https://doi.org/10.3390/curroncol31070278
APA Style
Abahssain, H., Souadka, A., Alem, R., Santoni, M., Battelli, N., Amela, E., Lemaire, A., Rodriguez, J., & Errihani, H.
(2024). Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting. Current Oncology, 31(7), 3771-3782.
https://doi.org/10.3390/curroncol31070278
